AstraZeneca holds talks with Bristol Myers Squibb on $400bn merger
AstraZeneca holds talks with Bristol Myers Squibb on $400bn merger
8.3Significance
7 sources6.4Source trust
Top stories · Organization
Tie-up
Connected in the knowledge graph
OrganizationBristol-Myers SquibbOrganizationPascal SoriotOrganizationPrincetonOrganizationBMSOrganizationAstraZenecaOrganizationBusinessOrganizationContinue
Latest coverage · 1 topic
Where Tie-up shows up